Comparison of Fenofibric Acid Bioavailability From 45 mg and 135 mg Strength ABT-335 Capsules.
Phase of Trial: Phase I
Latest Information Update: 14 Oct 2010
At a glance
- Drugs Choline fenofibrate (Primary)
- Indications Hyperlipidaemia
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Abbott Laboratories
- 23 Apr 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 03 Mar 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 13 Feb 2009 New trial record